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In this issue’s Clinical Research Capsule, we ask the
fundamental question: “Why care about research?” Clini-
cians sometimes have a distanced attitude towards research.
The reasons for this are many: conducting research is
difficult; it is only for those who are statistically minded; it
means having NIH or equivalent funding; finally, it does
not pertain to them as research is separate from patient care.
The notion that research is separate and without impact on
patient care could not be more erroneous.
Why care about clinical 
research?
• Our practice is our 
laboratory
• Some nuances of human 
disease not translatable 
from animal models 
(social admit reasons, 
“look sicker”, )
• Clinical research allows 
us to continually refine 
patient care
Let’s look at a few examples:
You are evaluating a patient with an acute ankle injury.
Do you recognize the following questions?
– Unable to bear weight immediately and in ED?
– Tender on the lateral malleolar tip or posterior aspect of
the lateral malleolus?
– Tender on the medial malleolar tip or posterior aspect
of the medial malleolus?
Most practicing emergency medicine clinicians will recog-
nize these as the questions used for the Ottawa ankle rule [1].
This was a prospective survey administered in two stages:
derivation and refinement of the original rules (first stage)
and validation of the refined rules (second stage). The cohort
consisted of a convenience sample of adults with acute ankle
injuries: 1,032 of 1,130 eligible patients in the first stage and
453 of 530 eligible patients in the second stage. While these
research method details may seem not useful to daily clinical
practice, the results derived from this study certainly are.
What about the following physical exam findings?
– No posterior midline cervical-spine tenderness
– No evidence of intoxication
– A normal level of alertness
– No focal neurologic deficit
– No painful distracting injuries
The above represent the NEXUS low risk criteria, which
state that if a patent has all of the above, then they do not
require cervical spine radiography [2]. This prospective
observational study was conducted across 21 centers in the
US. The study population consisted of 34,069 patients
evaluated by imaging of the cervical spine after blunt
trauma. Of these, 2.4% had radiographically documented
cervical-spine injury. These results yielded an overall
Int J Emerg Med (2008) 1:121–122
DOI 10.1007/s12245-008-0035-1
L. G. Stead :W. W. Decker
Department of Emergency Medicine,
Mayo Clinic College of Medicine,
Rochester, MN, USA
L. G. Stead (*)
Generose G-410, Department of Emergency Medicine,
Mayo Clinic,
200 First Street SW,
Rochester, MN 55905, USA
e-mail: stead.latha@mayo.edu
sensitivity of 99%, specificity of 12.9%, and a negative
predictive value of 99.8%. Again, while conducting such a
study may not appeal to everyone, the results from such
investigations do impact everyday patient care.
If the above two examples haven’t convinced you
clinical research directly impacts patient care, consider the
following case:
– A 45-year-old male presents to the ED with chest pain
of 2.5-h duration, radiating to the left arm, associated
with diaphoresis, relieved by sublingual nitroglycerin
in the ambulance, and rated 5/10. Family history is
unknown.
What blood test will you order?
The troponin story [3]:
– 855 patients with symptoms of acute myocardial
ischemia within 12 h of onset had serum troponin T,
CK-MB, and ECG done and analyzed in blinded
fashion. Logistic regression was used to assess the
usefulness of baseline levels of troponin T and CK-MB
vs. ECG findings (ST-segment elevation, ST-segment
depression, T-wave inversion, or the presence of
confounding factors that impair the detection of
ischemia). On admission, 289 of 801 patients with
base-line serum samples had elevated troponin T.
Mortality within 30 days was significantly higher in
these patients than in patients with lower levels of
troponin T (11.8% vs. 3.9%, P<0.001). Troponin T
levels remained significantly predictive of 30-day
mortality in a model that contained ECG categories
and CK-MB levels (chi-square=9.2, P=0.027). The
authors of the study concluded that cardiac troponin T
level is a powerful, independent risk marker in patients
who present with acute myocardial infarction.
– Today, most clinicians routinely use this serum marker,
perhaps not thinking about its origins from a research
study.
So, why care about clinical research?
Clinical research is the way in which we can scientifi-
cally study patient outcomes and thus deliver evidence-
based care. Our ED is our laboratory—where we are
continually gathering, classifying, and analyzing data.
While basic science and animal studies can provide
important clues to the underlying pathophysiology of many
human ailments, some nuances of human disease are not
translatable from these models. Referred to as “the
youngest science” by Lewis Thomas, the wonders of
modern medicine are a direct result of medical research.
Being involved in research offers the clinician the satisfac-
tion of discovery and contributing to the care of those
beyond the reach of her touch.
“The real voyage of discovery consists not in seeking
new landscapes, but in having new eyes.”
-Marcel Proust
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